You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

ACETIC ACID, GLACIAL - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for acetic acid, glacial and what is the scope of patent protection?

Acetic acid, glacial is the generic ingredient in fifteen branded drugs marketed by Actavis Mid Atlantic, Chartwell Rx, Kv Pharm, Rising, Sciegen Pharms, Sun Pharma Canada, Warner Chilcott, Hikma, B Braun, Baxter Hlthcare, Otsuka Icu Medcl, Bausch And Lomb, Pharmafair, Bayer Pharms, Cosette, Taro, Wockhardt, and Saptalis Pharms, and is included in twenty-four NDAs. Additional information is available in the individual branded drug profile pages.

Six suppliers are listed for this compound.

Summary for ACETIC ACID, GLACIAL
Recent Clinical Trials for ACETIC ACID, GLACIAL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Council of Science and Technology, MexicoPhase 4
National Institute of PerinatologyPhase 4

See all ACETIC ACID, GLACIAL clinical trials

US Patents and Regulatory Information for ACETIC ACID, GLACIAL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wockhardt HYDROCORTISONE AND ACETIC ACID acetic acid, glacial; hydrocortisone SOLUTION/DROPS;OTIC 040168-001 Aug 30, 1996 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Kv Pharm ACETIC ACID W/ HYDROCORTISONE acetic acid, glacial; hydrocortisone SOLUTION/DROPS;OTIC 085492-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Hikma VOSOL acetic acid, glacial SOLUTION/DROPS;OTIC 012179-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Actavis Mid Atlantic ACETASOL acetic acid, glacial SOLUTION/DROPS;OTIC 087146-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Pharmafair BOROFAIR acetic acid, glacial; aluminum acetate SOLUTION/DROPS;OTIC 088606-001 Aug 21, 1985 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
B Braun ACETIC ACID 0.25% IN PLASTIC CONTAINER acetic acid, glacial SOLUTION;IRRIGATION, URETHRAL 018161-001 Approved Prior to Jan 1, 1982 AT RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Baxter Hlthcare ACETIC ACID 0.25% IN PLASTIC CONTAINER acetic acid, glacial SOLUTION;IRRIGATION, URETHRAL 018523-001 Feb 19, 1982 AT RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Financial Trajectory for Glacial Acetic Acid

Last updated: February 15, 2026

Overview

Glacial acetic acid (99.5% anhydrous acetic acid) is a chemical primarily used in manufacturing acetic anhydride, vinyl acetate monomer, acetic esters, and as a solvent. It also finds application in the production of cellulose acetate, vinegar, and as a cleaning agent.

Market Size and Growth Trends

  • The global market for glacial acetic acid was valued at approximately USD 2.1 billion in 2021.
  • Expected compound annual growth rate (CAGR) from 2022 to 2030: 4.2% (Research and Markets, 2022).
  • Key demand drivers include increasing vinyl acetate monomer (VAM) production, growth in the textile and paper sectors, and expanding use in the food and beverage industry.

Supply Chain and Production

  • Major producers: Eastman Chemical Company, Celanese Corporation, Dow Chemical Company, and East Asia-Pacific regional producers.
  • Feedstock: Primarily methanol and acetylene-based processes.
  • Production costs are influenced by methanol prices, energy costs, and regulatory compliance costs related to environmental standards.

Regional Market Dynamics

  • Asia-Pacific dominates the market, accounting for over 45% of global consumption in 2021.
  • China leads in both production and consumption, driven by expanding chemical manufacturing capacity and infrastructure projects.
  • North America and Europe face supply constraints due to stricter environmental regulations and aging infrastructure, but benefit from higher-margin specialty applications.

Market Drivers

  • Demand for VAM in adhesives, paints, and coatings.
  • Growth in the textile industry, especially in Asia, which uses acetic acid derivatives.
  • Increased investment in chemical manufacturing capacity in emerging economies.
  • Rising applications in the food industry, such as vinegar production and food additives.

Market Challenges

  • Fluctuations in methanol and energy prices increase production costs.
  • Stringent environmental policies in Europe and North America elevate compliance costs.
  • Alternatives to acetic acid in certain applications may limit market growth.

Financial Trajectory

  • Revenue is projected to grow at a CAGR of 4.2%, reaching approximately USD 3.1 billion by 2030.
  • Profit margins are influenced by raw material costs; high methanol prices compress margins in volatile markets.
  • Capital expenditure has been increasing in recent years to expand capacity and retrofit facilities for cleaner production methods.

Investment and R&D Outlook

  • Companies are investing in sustainable production methods, like bio-based acetic acid, to mitigate regulatory risks.
  • R&D efforts aim to reduce production costs and improve process efficiency.
  • Mergers and acquisitions are active, focusing on expanding regional presence and technological capabilities.

Key Market Segments and Applications

Segment Share (2021) Growth Drivers
Vinyl acetate monomer (VAM) 35% Construction, adhesives, paints
Acetic anhydride 25% Pharmaceuticals, textiles
Food and beverages 15% Vinegar, food additives
Solvents and other chemicals 25% Coatings, cleaning agents

Regulatory Impact

  • The transition toward greener acetylation processes influences market structure.
  • Restrictions on emissions and effluents require manufacturers to adopt cleaner technology.
  • Stringent regulations can cause regional market shifts as compliance costs vary.

Conclusion

Glacial acetic acid market maintains steady growth, supported by expanding downstream industries and regional demand trends. Cost factors and regulatory compliance significantly influence profitability and capacity investments.


Key Takeaways

  • The market is projected to grow at approximately 4.2% annually through 2030.
  • Asia-Pacific dominates demand, with China leading in both supply and consumption.
  • Price volatility of raw materials like methanol and energy affects profit margins.
  • Sustainability initiatives and regulatory pressures are shaping future production processes.
  • Mergers and R&D investments aim to capture efficiency gains and meet environmental standards.

FAQs

  1. What are the main applications driving demand for glacial acetic acid?
    Vinyl acetate monomer production, acetic anhydride manufacturing, food additives like vinegar, and solvents.

  2. How do regional regulations impact the market?
    Stricter environmental policies in Europe and North America increase compliance costs, influencing regional production and trade flows.

  3. What distinguishes bio-based acetic acid?
    It is produced from renewable biomass, offering a sustainable alternative to fossil-based methods amid rising environmental regulations.

  4. Who are the leading producers globally?
    Eastman Chemical, Celanese, Dow Chemical, and regional producers in China and Southeast Asia.

  5. What are future growth opportunities?
    Expansion in Asia-Pacific, adoption of greener processes, and innovations in process efficiencies offer growth avenues.


Citations

[1] Research and Markets. "Global Glacial Acetic Acid Market Analysis," 2022.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.